Domain created to manage non eCTD4 controlled vocabularies required to support IDMP
|
HA Controlled Vocabulary
Controlled Vocabulary / Code System Name as defoined by the Health Authority
|
Term
Term Description as defined by the Health Authority
|
Code
Code, if any, associated with the term by the Health Authority
|
Agency
Name of the issuing Health Authority (abbreviation) that maintains the term and code
|
Status
Current status of the Term usage as defined by the Health Authority (e.g., Current, Retired, Deprecated)
|
|---|---|---|---|---|
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, SUSPENSION, EXTENDED RELEASE |
C42926
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, SUSPENSION, LIPOSOMAL |
C42951
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, SUSPENSION, SONICATED |
C42988
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INSERT |
C60933
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INSERT, EXTENDED RELEASE |
C42922
|
FDA | — |
| SPL Business Operation Qualifier Terminology | Intent to compound 506E (drug shortage) drugs |
C112087
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTERSTITIAL |
C38219
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRA-ABDOMINAL |
C38220
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRA-AMNIOTIC |
C38221
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRA-ARTERIAL |
C38222
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRA-ARTICULAR |
C38223
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRABILIARY |
C38224
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRABRONCHIAL |
C38225
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRABURSAL |
C38226
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INTRACAMERAL |
C64984
|
FDA | — |
| SPL Drug Route of Administration Terminology | Intracanalicular |
C132737
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACARDIAC |
C38227
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACARTILAGINOUS |
C38228
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACAUDAL |
C38229
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACAVERNOUS |
C38230
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACAVITARY |
C38231
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACEREBRAL |
C38232
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACISTERNAL |
C38233
|
FDA | — |
| SPL Drug Route of Administration Terminology | Intracochlear |
C184707
|
FDA | — |
| SPL Drug Route of Administration Terminology | INTRACORNEAL |
C38234
|
FDA | — |
Showing 126–150 of 401 terms . Data sourced from public health authority publications and updated periodically.